Cargando…
Overview of Differences and Similarities of Published Mixed Treatment Comparisons on Pharmaceutical Interventions for Multiple Sclerosis
INTRODUCTION: Mixed treatment comparisons (MTCs) are increasingly important in the assessment of the benefit–risk profile of pharmaceutical treatments for relapsing–remitting multiple sclerosis (RRMS). Interpretation of MTCs requires a clear understanding of the methods of analysis and population st...
Autores principales: | Pia Sormani, Maria, Wolff, Robert, Lang, Shona, Duffy, Steven, Hyde, Robert, Kinter, Elizabeth, Wakeford, Craig, Giovannoni, Gavin, Kleijnen, Jos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606374/ https://www.ncbi.nlm.nih.gov/pubmed/32978726 http://dx.doi.org/10.1007/s40120-020-00213-4 |
Ejemplares similares
-
A Systematic Review and Mixed Treatment Comparison of Pharmaceutical Interventions for Multiple Sclerosis
por: Giovannoni, Gavin, et al.
Publicado: (2020) -
Patient and physician preferences for multiple sclerosis treatments in Germany: A discrete-choice experiment study
por: Poulos, Christine, et al.
Publicado: (2020) -
Measuring the impact of multiple sclerosis: Enhancing the measurement performance of the Multiple Sclerosis Impact Scale (MSIS-29) using Rasch Measurement Theory (RMT)
por: Cleanthous, Sophie, et al.
Publicado: (2017) -
Trifluridine–Tipiracil for Previously Treated Metastatic Colorectal Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Ramaekers, Bram L. T., et al.
Publicado: (2017) -
Ticagrelor for Secondary Prevention of Atherothrombotic Events After Myocardial Infarction: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Pouwels, Xavier G. L. V., et al.
Publicado: (2018)